SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Howard who wrote (78)9/9/1997 6:14:00 AM
From: James Baker   of 569
 
I own BIOX and talked my retired gen surgeon father into buying it as well.

A few comments on recent posts:

1. a figure of about 30% of the sales $ end up as BIOX revenue has been given on this board or MF-AOL board. If the total product sales do reach 1bil than 300 mil to BIOX should be doable.

2. lets remember that surgeons like to do surgery and synvisc is not helping then do that. So it is very likely that synvisc will be used much more by medical type docs, both rheumotologists and ultimately if the product continues with clean record of success and patient acceptance general internists and family physicians are likely to use this product.

3. WA appears to have a good reputatuion and certainly powerful marketing ability. The original press release only noted "autumn" availability of synisc in the US.

4. Visit their web site. BIOX has several interesting product in development. I am not sure that they will have the market sales of synvisc however

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext